110 related articles for article (PubMed ID: 8804427)
1. Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system.
Kase R; Bierfreund U; Klein A; Kolter T; Itoh K; Suzuki M; Hashimoto Y; Sandhoff K; Sakuraba H
FEBS Lett; 1996 Sep; 393(1):74-6. PubMed ID: 8804427
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease.
Kase R; Bierfreund U; Klein A; Kolter T; Utsumi K; Itoha K; Sandhoff K; Sakuraba H
Biochim Biophys Acta; 2000 Jun; 1501(2-3):227-35. PubMed ID: 10838196
[TBL] [Abstract][Full Text] [Related]
3. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
[TBL] [Abstract][Full Text] [Related]
4. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.
Wilkening G; Linke T; Sandhoff K
J Biol Chem; 1998 Nov; 273(46):30271-8. PubMed ID: 9804787
[TBL] [Abstract][Full Text] [Related]
6. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
Henseler M; Klein A; Glombitza GJ; Suziki K; Sandhoff K
J Biol Chem; 1996 Apr; 271(14):8416-23. PubMed ID: 8626540
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Lansmann S; Moczall H; Bartelsen O; Weisgerber J; Sandhoff K
Biol Chem; 2001 Feb; 382(2):283-90. PubMed ID: 11308026
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid hydrolases and activator proteins.
Bierfreund U; Kolter T; Sandhoff K
Methods Enzymol; 2000; 311():255-76. PubMed ID: 10563332
[No Abstract] [Full Text] [Related]
9. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
[TBL] [Abstract][Full Text] [Related]
10. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
[TBL] [Abstract][Full Text] [Related]
13. pH-dependent conformational properties of saposins and their interactions with phospholipid membranes.
Vaccaro AM; Ciaffoni F; Tatti M; Salvioli R; Barca A; Tognozzi D; Scerch C
J Biol Chem; 1995 Dec; 270(51):30576-80. PubMed ID: 8530492
[TBL] [Abstract][Full Text] [Related]
14. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
[TBL] [Abstract][Full Text] [Related]
15. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Sadeghlar F; Mozcall H; Bernardo K; Schuchman E; Sandhoff K
J Biol Chem; 2001 Feb; 276(8):5760-8. PubMed ID: 11104761
[TBL] [Abstract][Full Text] [Related]
16. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity.
Remmel N; Locatelli-Hoops S; Breiden B; Schwarzmann G; Sandhoff K
FEBS J; 2007 Jul; 274(13):3405-20. PubMed ID: 17561962
[TBL] [Abstract][Full Text] [Related]
17. Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: patient variant Saposin A lacks lipid extraction capacity.
Locatelli-Hoops S; Remmel N; Klingenstein R; Breiden B; Rossocha M; Schoeniger M; Koenigs C; Saenger W; Sandhoff K
J Biol Chem; 2006 Oct; 281(43):32451-60. PubMed ID: 16905746
[TBL] [Abstract][Full Text] [Related]
18. Determination of saposin proteins (sphingolipid activator proteins) in human tissues.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Anal Biochem; 1990 Nov; 190(2):154-7. PubMed ID: 2127157
[TBL] [Abstract][Full Text] [Related]
19. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
[TBL] [Abstract][Full Text] [Related]
20. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
